Vivos (RDGL) EBT Margin Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Vivos | - | - | -3,105.00 | 1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -57,410.00 |
| Mar 31, 2025 | 929,139.00 |
| Sep 30, 2024 | -696,683.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -827,334.00 |
| Sep 30, 2023 | -527,589.00 |
| Jun 30, 2023 | -638,465.00 |
| Mar 31, 2023 | 124,525.00 |
| Sep 30, 2022 | -291,129.00 |
| Sep 30, 2021 | 58,577.00 |
| Sep 30, 2020 | 643,014.00 |
| Mar 31, 2018 | 515,505.00 |
| Mar 31, 2017 | 13.29 Mn |
| Sep 30, 2016 | 1.71 Mn |
| Mar 31, 2016 | -15.63 Mn |
| Mar 31, 2015 | 2.08 Mn |
| Mar 31, 2014 | -526,766.00 |
| Sep 30, 2013 | 279,663.00 |
| Mar 31, 2013 | -80,789.00 |
| Dec 31, 2012 | -433,860.00 |
| Sep 30, 2012 | -254,486.00 |
| Jun 30, 2012 | -339,903.00 |
| Mar 31, 2012 | -43,944.00 |
| Dec 31, 2011 | -133,567.00 |